Tech Blog

ShanX Medtech

Last verified 2026-05-08. JSON

The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.

Total raised$17.6Mattributed
Latest roundseed, $16.2M, 2026-02-01attributed
Founded2022
HeadquartersAmsterdam, Netherlands
Industryhealthtech
Stageseed
Websiteshanxmedtech.com

ShanX Medtech builds a rapid antimicrobial susceptibility testing platform that returns results in roughly one hour rather than 2-7 days. It serves hospitals and clinical labs treating bacterial infections, and antibiotic stewardship programs trying to reduce inappropriate prescribing. The sample-to-result time is the headline differentiator versus today's culture-based AST workflow.

Funding rounds

DateRoundAmountLead
2026-02-01seed$16.2Mundisclosed

Detected tech stack

PHP 8.3.30, Apache HTTP Server, Magnific Popup 1.1.0, Yoast SEO 27.0, Unpkg, imagesLoaded 5.0.0, parallax.js, Vercel Speed Insights, OWL Carousel, wpBakery, Bootstrap, MySQL

Provenance

FactStatusBasis
Seed, $16.2Mattributedsifted named as publisher. No document URL on file.
Total raised $17.6Mattributedsifted named as publisher. No document URL on file.
Company existenceself-reportedshanxmedtech.com, read 2026-05-08
Descriptionself-reportedshanxmedtech.com, read 2026-05-08

Nothing on this page is sourced yet. A sourced fact links to a document that states it.

Change history

No change recorded since records began on 2026-09-24.